NKGen Biotech, Inc. becomes a public company through business initiation
NKGen Biotech, Inc. (“NKGen”), a clinical-stage Natural Killer (NK) cell therapy company, has entered into a merger agreement with Graf Acquisition Corp. IV completed NKGen
Home » NKGen
NKGen Biotech, Inc. (“NKGen”), a clinical-stage Natural Killer (NK) cell therapy company, has entered into a merger agreement with Graf Acquisition Corp. IV completed NKGen
Recovery after a serious car accident often takes weeks to months, while severe injuries may require a year or longer. The first 72 hours usually
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents